Signal de tendance

Évolution des mentions ✨ Nouveau
30j7jMaintenant

10

mentions (7j)

10

mentions (30j)

5 juin 2026

premier signal

1

pays concernés

Contexte et analyse

Cette tendance "Clinical trial care and outcomes after glioblastoma diagnosis" a été détectée dans la catégorie Santé & Médecine avec un score de 100/100. Cette tendance connaît une croissance explosive et attire beaucoup d'attention actuellement.

Entités liées

https://www.uvm.edu/larnermed/medcommunications/news/todays-clinical-trials-are-tomorrows-standard-care-0https://www.cancernetwork.com/view/personalized-cancer-vaccine-pembrolizumab-feasible-effective-newly-diagnosed-gbmhttps://www.prnewswire.com/news-releases/diakonos-oncology-shares-updated-doc1021-gbm-survival-data-and-unveils-melanoma-clinical-study-at-asco-2026-302792148.htmlhttps://www.everydayhealth.com/cancer/groundbreaking-drug-may-double-survival-time-for-pancreatic-cancer/https://www.globenewswire.com/news-release/2026/06/03/3306413/0/en/Booking-Health-Announces-Release-of-Findings-on-International-Access-to-Personalized-Glioblastoma-Treatment-in-Germany.htmlhttps://www.clinicaltrialsarena.com/news/asco26-cancer-vaccines-and-at-home-injectable-drugs-continue-to-show-promise/https://www.stocktitan.net/news/INAB/in8bio-presents-updated-overall-survival-data-surpassing-19-5-months-5bk1ufdzzfeh.htmlhttps://rarecancernews.com/news/trial-data-back-glioblastoma-treatments-potential-extend-survival/https://www.earth.com/news/a-personalized-brain-cancer-vaccine-shows-a-survival-signal-one-patient-is-still-cancer-free-nearly-five-years-later/https://www.caledonianrecord.com/features/health/woman-remortgages-home-to-fund-cancer-treatment/article_9657e416-b4e1-538c-ba6f-1c5d96fe994a.html?mode=nowapp

Extraits des sources

We use cookies on our website to support technical features that enhance your user experience, and help us improve our website. By continuing to use this website, you accept our privacy policy I Understand Larner College of Medicine hide menu ! show the image caption close caption Rusty Ashmore (right) with his wife, Andrea After a glioblastoma diagnosis, Rusty Ashmore and his wife, Andrea, navigated treatment, clinical trial care, and the milestones that followed Health & Medicine June 4, 2026...

— uvm.edu

Ce que disent les sources

  • "After a glioblastoma diagnosis, a patient and his wife navigated standard treatments and clinical trial care, marking key milestones in their treatment journey."

    uvm.edu

  • "A personalized neoantigen vaccine (NeoVax) combined with pembrolizumab (Keytruda) yielded a median overall survival (OS) of 36.9 months in patients with..."

    cancernetwork.com

  • "PRNewswire/ -- Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and..."

    prnewswire.com

  • "Pancreatic cancer often spreads to other parts of the body before it's diagnosed, complicating treatment. But a new pill could finally change the status..."

    everydayhealth.com

  • "Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to..."

    globenewswire.com

  • "During the American Society of Clinical Oncology (ASCO) meeting 2026, data were presented for a number of cancer vaccines, including in melanoma,..."

    clinicaltrialsarena.com

  • "IN8bio (NASDAQ:INAB) reported updated data from its INB-200 Phase 1 and INB-400 Phase 2 studies of repeat-dose DeltEx DRI in newly diagnosed glioblastoma at..."

    stocktitan.net

  • "Add-on treatment with DeltEx DRI, a cell therapy being developed by In8bio, may help prolong survival in people with glioblastoma, an aggressive form of..."

    rarecancernews.com

  • "In the summer of 2021, a retired school nurse named Kim Garland noticed she was becoming forgetful about obvious things."

    earth.com

  • "By James Connolly. A woman with terminal brain cancer has remortgaged her home to fund pioneering treatment that she hopes will give her more time."

    caledonianrecord.com

Partager cette tendance

X LinkedIn